GleamWall
中文EN

MMM 3M CO

Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 66740 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY1.7%
TTM net income YoY4.0%
TTM EPS YoY7.0%
Revenue 3-yr CAGR-1.8%
Net income 3-yr CAGR—

Margins

Gross margin39.5%
Operating margin18.8%
Net margin14.0%
FCF margin10.6%
EBITDA margin24.4%

Returns

ROE80.8%
ROA9.2%
ROIC (approx.)28.5%
Asset turnover0.65x

Leverage & solvency

Liabilities / assets87.0%
Debt / equity3.63x
Current ratio1.41x
Interest coverage5.54x

Cash quality & payout

Operating cash flow / net income1.03x
Accruals ratio-0.2%
Payout ratio45.3%
Capex / revenue3.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$24.95B$24.57B
Cost of revenue$14.99B$14.45B
Gross profit$9.96B$10.13B
R&D expense—$700.00M
SG&A expense$4.00B$4.22B
Operating income$4.63B$4.82B
Interest expense$946.00M$1.19B
Pretax income$4.21B$4.82B
Income tax$1.00B$804.00M
Net income$3.25B$4.17B
EBITDA$5.94B$6.18B
EPS (basic)6.057.58
EPS (diluted)6.007.55
Dividends declared per share2.923.61
Weighted avg. shares (diluted)541.30M552.40M
Balance sheet
Cash & equivalents$5.24B$5.60B
Receivables$3.53B$3.19B
Inventory$3.66B$3.70B
Current assets$16.39B$15.88B
PP&E, net$7.10B$7.39B
Goodwill$6.42B$6.28B
Intangibles$1.10B$1.21B
Total assets$37.73B$39.87B
Current liabilities$9.60B$11.26B
Short-term debt$1.67B$1.92B
Long-term debt$10.93B$11.12B
Total debt$12.60B$13.04B
Total liabilities$32.99B$35.97B
Shareholders' equity$4.70B$3.84B
Net debt$7.37B$7.44B
Shares outstanding530.28M539.47M
Cash flow statement
Operating cash flow$2.31B$1.82B
Capital expenditure$910.00M$1.18B
Free cash flow$1.40B$638.00M
Investing cash flow$1.35B-$3.21B
Financing cash flow-$4.02B$1.10B
Depreciation & amortization$1.31B$1.36B
Stock-based compensation$225.00M$289.00M
Dividends paid$1.56B$1.98B
Share buybacks$3.25B$1.80B

Free plan shows the latest 2 periods; Pro shows all 19 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.